ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · Real-Time Price · USD
0.5873
-0.0002 (-0.03%)
At close: Apr 2, 2025, 4:00 PM
0.6089
+0.0216 (3.68%)
After-hours: Apr 2, 2025, 7:50 PM EDT

ZyVersa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-9.41-98.3-14.12-8.08-12.68
Depreciation & Amortization
0.010.010.010.010.01
Other Amortization
--0.040.320.29
Asset Writedown & Restructuring Costs
-93.33---
Stock-Based Compensation
0.711.193.584.143.68
Other Operating Activities
0.21-7.56-0.05-0.440.49
Change in Accounts Payable
0.752.414.54-0.31-0.6
Change in Other Net Operating Assets
0.180.191.12-0.713.71
Operating Cash Flow
-7.56-8.72-4.89-5.08-5.11
Long-Term Debt Issued
---5.231.69
Net Debt Issued (Repaid)
---5.231.69
Issuance of Common Stock
6.5419.08--3.02
Repurchase of Common Stock
--0.01---
Other Financing Activities
-0.59-2.42-0.1--0.14
Financing Cash Flow
5.955.961.875.234.56
Net Cash Flow
-1.61-2.76-3.020.15-0.55
Levered Free Cash Flow
-4.8-5.46-1.65-2.02-
Unlevered Free Cash Flow
-4.63-5.46-1.43-1.83-
Change in Net Working Capital
-1.08-2.35-3.631.27-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q